Diabetes drug shows potential in fighting cancer
The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major […]
» Read moreHome »
Clinicians should be on the lookout for immune-related adverse reactions (irAEs) even after patients have been receiving anti–programmed cell death […] Cancer is one of the top causes of death worldwide. The cancer burden is related not only to genetic predisposition, […] An international team today reports the findings of an independent assessment of five commercially-available assays for tumor DNA sequencing—a fast, […] An experimental immunotherapy that contains a genetically altered version of herpes simplex virus type 1 (HSV-1) was associated with a […] Hopes of a cure for brain cancer that killed former Labour MP Tessa Jowell with a new combination treatment in […] Adolescents and young adults (AYA) with cancer are often missing out on age-appropriate specialist care owing to a lack of […] Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Last year, cancer screening programs around […] According to the American Cancer Society, a noninvasive breast cancer called ductal carcinoma in situ (DCIS) accounts for approximately one […]
Adverse Reactions to Immunotherapy Can Appear After a Year
Mapping the paradigm shift of China’s cancer burden for designing prevention strategies
Cancer DNA blood tests validated by international research team
Deadly Brain Tumor: Survival Extended by Oncolytic Virus Product
Hopes of a cure for brain cancer that killed ex-Labour MP Tessa Jowell
Removing care inequalities for teens and young adults with cancer
Cancer Screening Stopped by Pandemic: Repercussions to Come?
Little boy with cancer fulfils dream of becoming police officer
Surgical technique may reduce positive margin rate in breast cancer patients with DCIS
